462 125 mg (Emend 125 mg)
Generic Name: aprepitant
Pill with imprint 462 125 mg is Pink & White, Capsule-shape and has been identified as Emend 125 mg. It is supplied by Merck & Company Inc..
Emend is used in the treatment of nausea/vomiting, chemotherapy induced; nausea/vomiting, postoperative and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Emend 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 462 125 mg
Emend
- Generic Name:
- aprepitant
- Imprint:
- 462 125 mg
- Strength:
- 125 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- NK1 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Merck & Company Inc.
- Inactive Ingredients:
- sucrose
microcrystalline cellulose
hydroxypropyl cellulose (type h)
sodium lauryl sulfate
gelatin
titanium dioxide
silicon dioxide
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.
More about Emend (aprepitant)
- Emend Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 13 Reviews
- Generic Availability
- Drug class: NK1 receptor antagonists
Consumer resources
Other brands: Cinvanti
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
